Xpert MTB/RIF ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection : a diagnostic accuracy evaluation

Show simple item record

dc.contributor.author Ghebrekristos, Yonas T.
dc.contributor.author Beylis, Natalie
dc.contributor.author Centner, Chad M.
dc.contributor.author Venter, Rouxjeane
dc.contributor.author Derendinger, Brigitta
dc.contributor.author Tshivhula, Happy
dc.contributor.author Naidoo, Selisha
dc.contributor.author Alberts, Rencia
dc.contributor.author Prins, Bronwyn
dc.contributor.author Tokota, Anitta
dc.contributor.author Dolby, Tania
dc.contributor.author Marx, Florian
dc.contributor.author Omar, Shaheed Vally
dc.contributor.author Warren, Robin
dc.contributor.author Theron, Grant
dc.date.accessioned 2024-08-20T11:51:07Z
dc.date.available 2024-08-20T11:51:07Z
dc.date.issued 2023-10
dc.description DATA SHARING : Study data can be accessed on request from the corresponding author without restriction. en_US
dc.description.abstract BACKGROUND : Xpert MTB/RIF Ultra (Ultra) is a widely used rapid front-line tuberculosis and rifampicin-susceptibility testing. Mycobacterium Growth Indicator Tube (MGIT) 960 liquid culture is used as an adjunct but is vulnerable to contamination. We aimed to assess whether Ultra can be used on to-be-discarded contaminated cultures. METHODS : We stored contaminated MGIT960 tubes (growth-positive, acid-fast bacilli [AFB]-negative) originally inoculated at a high-volume laboratory in Cape Town, South Africa, to diagnose patients with presumptive pulmonary tuberculosis. Patients who had no positive tuberculosis results (smear, Ultra, or culture) at contamination detection and had another, later specimen submitted within 3 months of the contaminated specimen were selected. We evaluated the sensitivity and specificity of Ultra on contaminated growth from the first culture for tuberculosis (next-available non-contaminated culture result reference standard) and rifampicin resistance (vs MTBDRplus on a later isolate). We calculated potential time-to-diagnosis improvements and also evaluated the immunochromatographic MPT64 TBc assay. FINDINGS : Between June 1 and Aug 31, 2019, 36 684 specimens from 26 929 patients were processed for diagnostic culture. 2402 (7%) cultures from 2186 patients were contaminated. 1068 (49%) of 2186 patients had no other specimen submitted. After 319 exclusions, there were 799 people with at least one repeat specimen submitted; of these, we included in our study 246 patients (31%) with a culture-positive repeat specimen and 429 patients (54%) with a culture-negative repeat specimen. 124 patients (16%) with a culture-contaminated repeat specimen were excluded. When Ultra was done on the initial contaminated growth, sensitivity was 89% (95% CI 84–94) for tuberculosis and 95% (75–100) for rifampicin-resistance detection, and specificity was 95% (90–98) for tuberculosis and 98% (93–100) for rifampicin-resistance detection. If our approach were used the day after contamination detection, the time to tuberculosis detection would improve by a median of 23 days (IQR 13–45) and provide a result in many patients who had none. MPT64 TBc had a sensitivity of 5% (95% CI 0–25). INTERPRETATION : Ultra on AFB-negative growth from contaminated MGIT960 tubes had high sensitivity and specificity, approximating WHO criteria for sputum test target product performance and exceeding drug susceptibility testing. Our approach could mitigate negative effects of culture contamination, especially when repeat specimens are not submitted. en_US
dc.description.department Medical Microbiology en_US
dc.description.librarian am2024 en_US
dc.description.sdg SDG-03:Good heatlh and well-being en_US
dc.description.sponsorship The European & Developing Countries Clinical Trials Partnership, National Institutes of Health. en_US
dc.description.uri www.thelancet.com/microbe en_US
dc.identifier.citation Ghebrekristos, Y.T., Beylis, N., Centner, C.M. et al. 2023, 'Xpert MTB/RIF ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation', Lancet Microbe, vol. 4, pp. e822-829. https://DOI.org/10.1016/S2666-5247(23)00169-6. en_US
dc.identifier.issn 2666-5247
dc.identifier.other 10.1016/ S2666-5247(23)00169-6
dc.identifier.uri http://hdl.handle.net/2263/97747
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.rights © 2023 The Author(s). This is an Open Access article under the CC BY-NC-ND 4.0 license. en_US
dc.subject Patients en_US
dc.subject Mycobacterium growth indicator tube (MGIT) en_US
dc.subject Xpert MTB/RIF Ultra (Ultra) en_US
dc.subject Tuberculosis testing en_US
dc.subject Rifampicin-susceptibility testing en_US
dc.subject Pulmonary tuberculosis (PTB) en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Xpert MTB/RIF ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection : a diagnostic accuracy evaluation en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record